arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

LENSAR, Inc.

LNSR
$7.23 ▲ +0.05 (+0.63%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
31 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
50
Health
Fair
Neutral
auto_awesome

Analytical Summary

LENSAR, Inc. shows mixed fundamentals. On the positive side, Return on Common Equity (%) remains strong. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $88.9M
Dividend Yield
Revenue Growth 18.4%
Op. Margin 12.9%
ROIC 11.3%
FCF / Share $-0.01
Trailing P/E 51.6x
Price / Book 6.0x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 22, 2026.

31-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$16.50M
↑ +18.4%
Net Income Profit after all expenses
$36.33M
— 0.0%
Operating Margin Operating profit as % of sales
12.9%
↓ -22.4% 6th
FCF / Share Free cash flow per share
$-0.01
↑ +97.1%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
6
Returns
100
Cash Quality
37

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 31 quarters